Polocaine

Polocaine

Polocaine Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

LOCAL ANESTHETICS SHOULD ONLY BE EMPLOYED BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES WHICH MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED, AND THEN ONLY AFTER INSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY RESUSCITATIVE EQUIPMENT, AND THE PERSONNEL RESOURCES NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES. (See also  ADVERSE REACTIONS and PRECAUTIONS.)  DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE, AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH.

            Local anesthetic solutions containing antimicrobial preservatives (ie, those supplied in multiple-dose vials) should not be used for epidural or caudal anesthesia because safety has not been established with regard to intrathecal injection, either intentionally or inadvertently, of such preservatives.

            It is essential that aspiration for blood or cerebrospinal fluid (where applicable) be done prior to injecting any local anesthetic, both the original dose and all subsequent doses, to avoid intravascular or subarachnoid injection.  However, a negative aspiration does not ensure against an intravascular or subarachnoid injection.


            Reactions resulting in fatality have occurred on rare occasions with the use of local anesthetics.

            Mepivacaine with epinephrine or other vasopressors should not be used concomitantly with ergot-type oxytocic drugs, because a severe persistent hypertension may occur.  Likewise, solutions of mepivacaine containing a vasoconstrictor, such as epinephrine, should be used with extreme caution in patients receiving monoamine oxidase inhibitors (MAOI) or antidepressants of the triptyline or imipramine types, because severe prolonged hypertension may result.

            Local anesthetic procedures should be used with caution when there is inflammation and/or sepsis in the region of the proposed injection.

            Mixing or the prior or intercurrent use of any local anesthetic with mepivacaine cannot be recommended because of insufficient data on the clinical use of such mixtures.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

POLOCAINE (Mepivacaine HCl Injection, USP), is indicated for production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks.

            The routes of administration and indicated concentrations for mepivacaine are:

  

local infiltration                           0.5% (via dilution) or 1%

peripheral nerve blocks

 

                                 1% and 2%

 

epidural block

 

                            1%, 1.5%, 2%

 

caudal block

 

                            1%, 1.5%, 2%

 


            See DOSAGE AND ADMINISTRATION for additional information.  Standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of mepivacaine.

History

There is currently no drug history available for this drug.

Other Information

Mepivacaine hydrochloride is 2-Piperidinecarboxamide, N-(2, 6-dimethylphenyl)-1-methyl-, monohydrochloride and has the following structural formula:

Polocaine Chemical Structure


The molecular formula is C15H22N2O • HCl.

            It is a white, crystalline odorless, powder, soluble in water, but very resistant to both acid and alkaline hydrolysis.

            Mepivacaine hydrochloride is a local anesthetic available as sterile isotonic solutions (clear, colorless) in concentrations of 1%, 1.5% and 2% for injection via local infiltration, peripheral nerve block, and caudal and lumbar epidural blocks.

            Mepivacaine hydrochloride is related chemically and pharmacologically to the amide-type local anesthetics.  It contains an amide linkage between the aromatic nucleus and the amino group.



Composition of Available Solutions*

 

1%

Single

Dose

30 mL

Vial

mg/mL

 

1%

Multiple

Dose

50 mL

Vial

mg/mL

 

1.5%

Single

Dose

30 mL

Vial

mg/mL

 

2%

Single

Dose

20 mL

Vial

mg/mL

 

2%

Multiple

Dose

50 mL

Vial

mg/mL

 

Mepivacaine hydrochloride

 

      10      

 

      10      

 

      15      

 

      20      

 

      20      

 

Sodium chloride

 

6.6

 

7

 

5.6

 

4.6

 

5

 

Potassium chloride

 

0.3

 


0.3

 

0.3

 


Calcium chloride

 

0.33

 


0.33

 

0.33

 


Methylparaben

 


1

 



1

 

*In Water for Injection

 

 

            The pH of the solution is adjusted between 4.5 and 6.8 with sodium hydroxide or hydrochloric acid.

Polocaine Manufacturers


  • App Pharmaceuticals, Llc
    Polocaine (Mepivacaine Hydrochloride) Injection, Solution Polocaine-mpf (Mepivacaine Hydrochloride) Injection, Solution [App Pharmaceuticals, Llc]
  • Dentsply Pharmaceutical
    Polocaine (Mepivacaine Hydrochloride) Injection, Solution [Dentsply Pharmaceutical]

Login To Your Free Account